Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Nasdaq:ONTX

Press/Media

Period7 Jul 2020

Media coverage

9

Media coverage